FILTER BY:
Details
A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors
Address: 1515 Holcombe Blvd, Houston, TX 77030, USA
Phone: 877-451-7009
Mesothelioma Type:
- Pleural: True
- Peritoneal: True
- Pericardial: True
- Tunica Vaginalis: True
Type: Epitheliod, Sarcomatoid, Biphasic
Condition: Mesothelioma, Epithelioid Hemangioendothelioma(EHE), Solid Tumor
Description: The goal of this open-label, dose escalation and dose expansion Phase I clinical trial is to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of BGC515 administered once daily in 3 weeks cycles in solid tumor patients.
Research Center: MD Anderson Cancer Center
Treatment Interventions: DRUG: BGC515
Potential Impact: Fake Data
Clinical Trial Number: NCT06452160
Phase: Phase 1
Status: Recruiting
